trova@unifi(opens in a new window)|View at Publisher| Export | Download | Add to List | More... Current Medicinal Chemistry Volume 17, Issue 10, April 2010, Pages 915-928 Dihydrobenzo[1,4]oxathiine: A multi-potent pharmacophoric heterocyclic nucleus (Review) Viglianisi, C., Menichetti, S. Dipartimento di Chimica U. Schiff, Laboratorio di Progettazione, Sintesi e Studio di Eterocicli Biologicamente Attivi (HeteroBioLab), Polo Scientifico e Tecnologico - Università di Firenze, Via della Lastruccia, 13, 50019 Sesto Fiorentino - Firenze, Italy View references (99) Abstract 2,3-dihydrobenzo[b][1,4]oxathiine represents a valuable pharmacophoric heterocyclic nucleus known since very long time. Initially, together with some patents reporting the use of these compounds as herbicides or lipogenesis inhibitors, several papers reported their ability as melatonin, histamine and serotonin receptor ligands, α-adrenoreceptor blockers as well as non-glycoside sweeteners. This wide range of biological activities has been recently further improved by studies stating their activity as antimycotics, multi-defense antioxidants and estrogen receptor ligands. The last insights regarding the preparation, the biological activity and the structure activity relationship (SAR) of derivatives containing the dihydrobenzoxathiine skeleton will be discussed in this review.

Dihydrobenzo[1,4]oxathiines: A multi-potent pharcophoric heterocyclic nucleus / C. Viglianisi; S. Menichetti. - In: CURRENT MEDICINAL CHEMISTRY. - ISSN 0929-8673. - STAMPA. - 17(2010), pp. 915-928. [10.2174/092986710790820697]

Dihydrobenzo[1,4]oxathiines: A multi-potent pharcophoric heterocyclic nucleus

VIGLIANISI, CATERINA;MENICHETTI, STEFANO
2010

Abstract

trova@unifi(opens in a new window)|View at Publisher| Export | Download | Add to List | More... Current Medicinal Chemistry Volume 17, Issue 10, April 2010, Pages 915-928 Dihydrobenzo[1,4]oxathiine: A multi-potent pharmacophoric heterocyclic nucleus (Review) Viglianisi, C., Menichetti, S. Dipartimento di Chimica U. Schiff, Laboratorio di Progettazione, Sintesi e Studio di Eterocicli Biologicamente Attivi (HeteroBioLab), Polo Scientifico e Tecnologico - Università di Firenze, Via della Lastruccia, 13, 50019 Sesto Fiorentino - Firenze, Italy View references (99) Abstract 2,3-dihydrobenzo[b][1,4]oxathiine represents a valuable pharmacophoric heterocyclic nucleus known since very long time. Initially, together with some patents reporting the use of these compounds as herbicides or lipogenesis inhibitors, several papers reported their ability as melatonin, histamine and serotonin receptor ligands, α-adrenoreceptor blockers as well as non-glycoside sweeteners. This wide range of biological activities has been recently further improved by studies stating their activity as antimycotics, multi-defense antioxidants and estrogen receptor ligands. The last insights regarding the preparation, the biological activity and the structure activity relationship (SAR) of derivatives containing the dihydrobenzoxathiine skeleton will be discussed in this review.
17
915
928
C. Viglianisi; S. Menichetti
File in questo prodotto:
File Dimensione Formato  
2010_CurrMedChem_2010_915.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: DRM non definito
Dimensione 349.45 kB
Formato Adobe PDF
349.45 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2158/386210
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 12
social impact